Subscribe to this column
L. Michael Glode, MD, FACP, FASCO
L. Michael Glodé, MD, FACP, FASCO, is a professor emeritus at the University of Colorado Cancer Center. He previously served as chair of ASCO's Integrated Media and Technology and Cancer Education Committees. He is the author of prost8blog, a blog to help patients and their families understand various aspects of prostate cancer.
Mar 05, 2015
I recently attended the co-sponsored Genitourinary Cancers Symposium. As usual, it was somewhat of a “firehose to take a drink” scenario with great presentations, more posters than you could possibly absorb, and lots of progress on many fronts.
Feb 03, 2015
In the past decade, a number of labs and companies have developed techniques to further define how a patient with prostate cancer, or suspected cancer, is likely to do. There are at least a dozen tests that are in various stages of commercialization, and it would be difficult to do justice to all...
Jan 07, 2015
It is always humbling to see how much you can miss in trying to keep up with medicine's developments, even in an incredibly narrow area like prostate cancer. Fortunately, there are many crutches like Medscape that offer help (along with targeted ads of course).
Dec 17, 2014
Several patients/friends recently told me about the 60 Minutes piece highlighting the ongoing efforts of Patrick Soon-Shiong, a surgeon who was involved in the development of...
Oct 31, 2014
How to answer this very common question is a pretty daunting task. Last week, I was at the Prostate Cancer Foundation annual scientific retreat. This is the ultimate place...
Jul 22, 2014
The use of statins to control dyslipidemia is now over 20 years old and supported for patients with coronary artery disease by the landmark Scandanavian Simvastatin Survival Study published in 1994....
Latest Blogs